We present evidence of complex balancing regulation of HTR1B transcription by common polymorphisms in its promoter. Computational analysis of the HTR1B gene predicted that a 5 0 segment, spanning common DNA sequence variations, TÀ261G, AÀ161T, and À182INS/ DELÀ181, contained a putative functional promoter. Using a secreted alkaline phosphatase (SEAP) reporter gene system, we found that the haplotype À261G_À182INSÀ181_AÀ161 enhanced transcriptional activity 2.3-fold compared with the haplotype TÀ261_À182INSÀ181_AÀ161. Conversely, À161T reversed this, and the net effect when À261G and À161T were in the same haplotype (À261G_À182INSÀ181_À161T) was equivalent to the major haplotype (TÀ261_À182INSÀ181_AÀ161). Electrophoretic mobility shift experiments showed that À261G and À161T modify the binding of transcription factors (TFs): À261G generates a new AP2 binding site, while alleles AÀ161 and À161T exhibit different binding characteristics to AP1. TÀ261G and AÀ161T were found to be in linkage disequilibrium (LD) with G861C in a European ancestry population. Interestingly, G861C has been reported to be associated with several psychiatric disorders. Our results indicate that HTR1B is the target of substantial transcriptional genetic regulation by common haplotypes, which are in LD with the HTR1B single-nucleotide polymorphism (SNP) most commonly used in association studies. Molecular Psychiatry (2003) 8, 901-910.
Introduction
Serotonin (5-hydroxytryptamine, 5-HT) plays an essential role in various brain functions including feeding, sleep, pain, mood, aggression, thermoregulation, locomotion, and learning, and components of the serotonin pathways are common psychopharmacological targets. 1 Serotonin elicits its effects through a superfamily of serotonin receptors (HTR 1-7). The subtypes HTR1A-F upon activation at low concentrations of serotonin inhibit adenylyl cyclase (types V and VI) through coupling with G i a.
2,3 HTR1B is a presynaptic and postsynaptic receptor widely distributed in the basal ganglia, hippocampus, and cortex. HTR1B has a role in multiple behavioral traits, such as locomotion, feeding, and thermoregulation, and also in arterial contractile regulation mechanisms, 3, 4 and has been the focus of much neuropsychiatric and neuropharmacological research. HTR1B knockout mice display a variety of interesting behavioral changes, such as increased aggression, decreased anxiety behavior, increased impulsivity, elevated alcohol consumption, increased cocaine seeking behavior, and decreased anxiety behavior (see Sanders et al 5 for a review). Interestingly, overexpression of HTR1B in rat dorsal raphe nucleus has been shown to increase anxiety behavior after inescapable stress. 6 The human HTR1B does not have introns. It is located at 6q14.1, within the region 6q13-q26 that has been implicated as harboring a schizophrenia susceptibility gene (SCZD5). 7 Many mutation scans have identified a number of polymorphisms in the coding sequence and surrounding 5 0 -and 3 0 -untranslated regions (UTRs), [8] [9] [10] [11] [12] [13] [14] [15] and over 20 association studies have been published with varied results. 5 The polymorphisms include five missense mutations, including T371G that causes a rare phenylalanineto-cysteine amino-acid change (Phe124Cys) with 124Cys exhibiting higher affinity for various receptor ligands. 16 Association tests of T371G and schizophrenia, bipolar disorders, and eating disorders have yielded negative results. 8, [16] [17] [18] G861C, a synonymous ('silent') SNP, has been commonly used for the study of association since it is quite informative. 5 A variety of reports of association of G861C have been published to phenotypes such as: antisocial alcoholism in the Finnish; 19 alcoholism in the presence of inactive aldehyde dehydrogenase 2 (ALDH2) in the Japanese; 20 a history of suicide attempts in EuropeanAmerican personality disorder patients; 21 minimum lifetime body mass index in Canadian bulimia nervosa patients; 22 and obsessive compulsive disorder. 23 Interestingly, it has been observed that the binding to HTR1B is increased in subjects homozygous for G861 13 providing a potential physiological basis for these associations. However, it is more likely that another variant (eg in the promoter region) in LD with G861C is the underlying mechanism for the alteration in binding to HTR1B associated with G861C.
Transcriptional regulation results from interactions among a variety of TFs and regulatory DNA sequence elements. It has been estimated that roughly 5-10% of the genes in the human genome encode TFs. 24 Naturally occurring genetic polymorphisms in promoters contribute to the observed variation of human gene expression in vivo. 25 There is also evidence that common genetic variation in the 5 0 -UTR that alters gene expression can be of pathophysiological importance. For example, an insertion/deletion polymorphism (A,ÀA) in the upstream promoter region of the PSEN2 (presenilin 2) gene, when homozygous (ÀA/ÀA), has been suggested to increase the risk for Alzheimer disease; DNA-protein binding analysis experiments suggested that this site interacts with a TF. 26 An SNP in the human SCGB3A2 (secretoglobin, family 3A, member 2) promoter that regulates transcription was reported associated with asthma, 27 and an SNP in the promoter of the human UCP2 (uncoupling protein 2 (mitochondrial, proton carrier)) was reported to be associated with risk of obesity. 28 Several polymorphisms have been described in the 5 0 -UTR of HTR1B, namely, GÀ511T,
À184INS/DELÀ183, 14 182INS/DELÀ181, 8 À179INS/ DELÀ178, 9 and AÀ161T. 8 Furthermore, previous work has shown that AÀ161T modified transcriptional activity in choriocarcinoma and colon adenocarcinoma cell lines. 15 We deemed it important, however, to further investigate AÀ161T in cell models closer to serotonergic neurons, and to design a study that would model the naturally occurring haplotypes of human populations. We have found that haplotypes of the HTR1B promoter predict the overall effect of genetic variation on the transcription of HTR1B better than individual polymorphisms. 31 and TSSG, based on the TF database TFD, 32 were used.
Materials and methods

In silico analysis
Construction of HTR1B reporter vectors PCR was used to amplify from human genomic DNA an HTR1B segment (À1387 to À1 bp upstream the start codon ATG) spanning various naturally occurring haplotypes for polymorphisms TÀ261G, À182INS/DELÀ181, and AÀ161T. The generated HTR1B segment was cloned into the XhoI/EcoRI site of the promoterless, enhancerless reporter vector pSEAP2-Basic (Clontech, Palo Alto, CA, USA), with the reporter gene encoding secreted alkaline phosphatase (SEAP) under the control of the inserted putative promoter sequence. DNA sequencing was used to confirm there were no other DNA variants, except for TÀ261G, À182INS/DELÀ181 and AÀ161T, in the 1387 bp HTR1B promoter segment. The haplotype of the putative promoter segment of HTR1B in each construct was verified by DNA sequencing, and the constructed reporter plasmid DNA were prepared for transfection using the StrataPrep s EF Plasmid Midprep Kit (Stratagene, La Jolla, CA, USA).
Cell lines and cell culture A CHOÀK1 cell line, purchased from American Type Culture Collections (ATCC, Manassas, VA, USA), was cultured in Ham's F-12 medium supplemented with 10% fetal bovine serum (FBS) (ATCC). Human neuroepithelioma cell line (SK-N-MC) (ATCC) was cultured in the minimum essential medium Eagle with 2 mM L-glutamine and Earle's BSS adjusted to contain 1.5 g/l sodium bicarbonate, 0.1 mM nonessential amino acids, and 1.0 mM sodium pyruvate, in the presence of 10% FBS. Human cortical neuron cell line (HCN-1A) (ATCC) was cultured in Dulbecco's modified Eagle's medium (DMEM) with 4 mM L-glutamine adjusted to contain 1.5 g/l sodium bicarbonate, 4.5 g/l glucose, in the presence of 10% FBS. The immortalized rat amygdalar neuron cell line (AR-5), 33 generously provided by Dr JW Kasckow (University of Cincinnati College of Medicine, Cincinnati, OH, USA), was cultured in a DMEM/F-12 medium mix. 33 All the cells were cultured in a humidified atmosphere of 5% CO 2 at 371C.
Transfection and SEAP reporter assays Cells were plated in 24-well plates (5 Â 10 4 cells/well for CHO-K1 cell line and 1 Â 10 5 cells/well for the other cell lines) and grown overnight to 60-70% confluence. Transient transfection was performed with LipofectAMINE (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Cells were transfected with 0.4 mg of the reporter construct or control plasmid pSEAP basic. pCMV-b-gal (0.1 mg) (Stratagene) was cotransfected with reporter construct to standardize for transfection efficiency. Cell culture media between 48 and 96 h after transfection were taken for the SEAP reporter assay. The SEAP reporter assay was carried out with the Great EscAPe SEAP Chemiluminescence kit (Clontech) on a white opaque 96-well flat-bottom microplate according to the manufacturer's protocol. The SEAP activities were normalized by b-galactosidase activities measured from lysed cell pellets using a commercially available ELISA kit (Stratagene).
Oligonucleotides and probes for electrophoresis mobility shift assay (EMSA) EMSA was performed using 22-bp oligonucleotides spanning SNPs AÀ161T or TÀ261G. The oligonucleotides were chemically synthesized by Sigma-Genosys (Woodlands, TX, USA). When used as EMSA probes, double-stranded oligonucleotides (3.5 pmol) were end-labeled at 371C for 10 min in the presence of 10 mCi of [ 32 P]-g-ATP (3000 Ci/mmol; Amersham Biosciences, Piscataway, NJ, USA) and 5 U of T4 polynucleotide kinase (Promega, Madison, WI, USA). The radiolabeled probes were separated from free nucleotide by NucTrap columns (Stratagene).
Nuclear extract (NE) preparation
About 10 7 cells were washed twice with ice-cold PBS and scraped off the plates. Then the cells were resuspended in 1 ml of ice-cold hypotonic buffer (20 mM HEPES-HCl, pH 7.6; 1 mM EDTA, 10 mM NaCl, 14 mM 2-mercaptoethanol, 0.5% Nonidet P-40) in the presence of protease inhibitors (1 mM PMSF, 10 mg/ml each of leupeptin, aprotinin, and pepstatin) and phosphatase inhibitors (5 mM b-glycerol phosphate, 1 mM benzamidine, and 1 mM sodium fluoride), and incubated for 15 min on ice. Tubes were vortexed briefly, and then centrifuged for 30 s at 16 000 g at 41C. The pellet nuclei were washed twice with ice-cold hypotonic buffer, and then extracted for 20 min on ice with 100 ml of extraction buffer (20 mM HEPES-HCl, pH 7.6; 1 mM EDTA, 430 mM NaCl, 14 mM 2-mercaptoethanol, 0.5% Nonidet P-40) in the presence of protease inhibitors and phosphatase inhibitors. NEs were obtained as supernatant by centrifugation for 10 min at 16 000 g at 41C. Protein concentrations were determined by bicinchoninic acid assay (Pierce, Rockford, IL, USA).
EMSA NEs (1-5 mg) from cell lines CHO-K1, SK-N-MC, AR-5, or HCN-1A were incubated in a 10 ml of binding reaction for 10 min on ice with optimized binding buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM MgCl 2 , 5 mM EDTA, 2.5 mM DTT, 4% glycerol, and 0.1 mg poly dI-dC) in the presence or absence of 50-100-fold molar excess of unlabeled oligonucleotide competitors. A [ 32 P]-labeled probe (1 ml) was then added to the binding reaction for an additional 20 min incubation on ice. After incubation, the binding reactions were then run on a nondenaturing 4% polyacrylamide gel in 0.25 Â TBE at 100 V for 1-2 h. Dried gels were exposed overnight to a Phosphostorage Screen (Amersham Biosciences). For the supershift assays, antibody (3 mg) to AP-2a, c-Jun or c-Fos (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was incubated with NEs at 41C for 2 h before incubation with probe.
Subjects, genotyping, and haplotype analysis
The three schizophrenia pedigree collections, contributing a combined 830 individuals from 193 families with 267 unrelated members for the current analysis, are described well in the literature, 7, 34, 35 and further summarized elsewhere with respect to ascertainment, recruitment, assessment, phenotyping, typical pedigree structure, exclusion of bilinearity, and racial/ethnic composition. 8 In brief, the Cao et al families contained 82 schizophrenia families with 371 individuals, consisting of 75% European Americans and 2% African Americans; the Cloninger et al families contained 75 families with 340 individuals, consisting of 61% European Americans and 36% African Americans; the Levinson et al families contained 36 families with 119 individuals, consisting of 75% European Americans and 18% African Americans. 7, 34, 35 These three collections had been previously genotyped for HTR1B variants, À182INS/DELÀ181, AÀ161T, and G861C, with the methods previously described, 8 and for the current paper we additionally genotyped TÀ261G to further enable the haplotypic and intermarker LD analyses. For À261G, we used the template-directed dye-terminator incorporation with fluorescence-polarization detection (FP-TDI) method. 36 Briefly, after PCR amplification with HotStart Taq DNA polymerase (Qiagen, Valencia, CA, USA) in 96-well plates, the remaining primer and dNTP were degraded with shrimp alkaline phosphatase (Roche, Indianapolis, IN, USA) and E. coli exonuclease I (Amersham Biosciences). Then, the singlebase extension was performed in a mixture of a specific TDI primer, 4 dye (TAMARA, ROX, R6G and R110)-labeled ddNTPs, and Thermosequenase (Amersham Biosciences). Finally, FP was detected by an Analyst fluorescence reader (LJL Biosystems, Sunnyvale, CA, USA), and FP data were converted to genotypes with an automated genotype calling spreadsheet. 37 Haplotype frequencies were inferred by familial relationships and then run through PHASE 1.0. 38 LD among polymorphisms was measured by haploXT.
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Results
Characterization of the HTR1B promoter sequence
Regulatory sequences tend to be highly conserved among mammals, 40 and their comparison is a useful strategy for identifying the sequences involved in transcriptional regulation. 29, 41, 42 Therefore, genomic sequences containing the 5 0 upstream region (about 4 kb upstream of the ATG start codon) of the mouse and human HTR1B genes were compared with the program PipMaker. 29 The analysis demonstrated that a large portion of this region (from À3288 to À1 bp of human HTR1B sequence) contains conserved sequence segments with identity higher than 50%, and with no homology for the remaining sequences. A higher percent identity spans from À1591 to À1 (Z63%) with À1009 to À592 showing the highest identity (Z75%) (Figure 1 ). This suggests that the regulatory elements for HTR1B expression might reside within the 5 0 sequence spanning from À3288 to À1 bp, but the most essential regulatory promoter elements likely span À1591 to À1 bp. Another program, Promoter 2.0, 30 predicted a vertebrate PolII promoter around position À733 bp (score: 1.217; scores above 1.0 are about 95% likely). Finally, TSSG predicted a promoter around position À879 bp, spanning a TATA box from À911 to À906 bp (TATAAA). Based on these analyses and also on the suitability of appropriate PCR primers, we selected a subregion of 1387 bp (À1387 to À1 bp) for further experimental work.
5
0 -UTR polymorphisms modify transcriptional activity An SEAP reporter gene system was used to measure the promoter activity of the 1387 bp putative promoter segment of HTR1B (Figure 2a) . Initially, four cell lines were selected for testing the HTR1B promoter activity. The control SK-N-M cell line had been previously shown to have no HTR1B mRNA expression. 43 CHO-K1 cell line has been commonly used for the functional characterization of HTR1B. The HCN-1A cell line is a human cortical neuron cell line, while the expression of human HTR1B mRNA had been previously detected in frontal cortex of human brain. 43 The AR-5 cell line is a derivative of the rat amygdala, and expression of HTR1B mRNA had been detected in the monkey amygdala. 33, 43, 44 Robust reporter activity was observed in either HCN-1A (24-fold of basal transcriptional level generated by control construct pSEAP-Basic) or CHO-K1 cells (five-fold of basal transcriptional level), but not in AR-5 cells or SK-N-M cells (1-and 0.7-fold of basal transcriptional level, respectively). To further analyze the effect of genetic variation, different naturally occurring haplotypes were generated by PCR and the transcriptional activities were compared (Figure 2) . The promoter segment with the haplotype À261G_À182INSÀ 181_AÀ161 showed a 2.3-fold enhanced transcriptional activity compared with the major haplotype TÀ261_À182INSÀ181_AÀ161, indicating that TÀ261G is functional, and that À261G increases transcription (P¼0.002, paired t-test). Haplotype À261G_À182INSÀ181_À161T exhibited a similar transcriptional activity to the major haplotype TÀ261_À182INSÀ181_AÀ161 (P¼0.7418, paired ttest), indicating that AÀ161T is also functional, and that allele À161T can actually reverse the effect of À261G. We did not detect a difference of transcriptional activity between À261G_À182INSÀ 181_AÀ161 and À261G_À182DELÀ181_AÀ161 (P¼0.0908, paired t-test), although the latter haplotype increased transcription relative to the major haplotype (TÀ261_À182INSÀ181_AÀ161) 2.8-fold (P¼0.0013, paired t-test). We also observed similar effects for the functional alleles À261G and À161T when the promoter activities were assayed in CHO-K1 cells (data not shown). However, in a previous study the allele À161T was shown to increase the transcription in a human colon adenocarcinoma cells line (COLO 320 DM), 15 suggesting the functional effect of allele À161T may be tissue-specific.
À261G generates a new AP2 binding site
To understand the mechanism responsible for the increased transcriptional activity of À261G, the 1387 bp sequence of the HTR1B 5 0 -UTR encompassing TÀ261G was analyzed for the presence of potential TF binding sites by a popular TF prediction tool, MatInspector. 31 Although no potential TF binding site was predicted either for TÀ261 or À261G, an EMSA experiment showed a DNA-protein binding band when we incubated a 22 bp synthetic À261G allelic oligonucleotide probe (Figure 3 ) with NE from CHO-K1 cells or HCN-1A cells (Figure 4a ), indicating that there is a potential TF binding site within the sequence of the À261G allelic probe. No DNA-protein binding was observed for the TÀ261 allelic probe (Figure 4a ), suggesting that À261G generates a new TF binding site. Furthermore, specificity of the binding between a putative TF and the À261G probe was demonstrated by competitive binding. While cold À261G probe eliminated the DNA-protein binding complex, cold TÀ261 probe did not influence it (Figure 4b ). Furthermore, À261G allele-specific binding was absent for NEs from SK-N-MC cells and AR5 cells (Figure 4a ), suggesting that this particular TF is cell line dependent. Interestingly, TSSG 32 predicted there is a TF AP2 binding site at À261G, but not at TÀ261, although MatInspector failed to predict it, which suggests a limitation in the latter's sensitivity perhaps related to the fact that MatInspector only uses the TF binding site database TRANSFAC. 31 As shown in Figure 4c , addition of anti-AP2 antibody generated a supershifted complex (the supershifted complex contains anti-AP2, AP2, and DNA, which exhibits a slower electrophoresis mobility than the complex containing only AP2 and DNA), -HCN  HCN  HCN  HCN  HCN  HCN  HCN  HCN  CHO SK  SK  AR5  AR5  HCN  HCN  CHO   10  9  8  7  6  5  4  3  2 
T-261 (100×) supporting the interpretation that it was TF AP2 that specifically bound to the À261G probe.
Differential binding of oligos AÀ161 and À161T to a component of the AP1 family We next explored the possible mechanism that underlies the functional effect of AÀ161T on transcriptional activity. MatInspector 31 had predicted an AP1 site spanning AÀ161T, which although not changing the core sequence (TGAC) of the AP1 site, altered its matrix similarity (ie, a score that indicates the similarity between a test sequence and a TF matrix that contains both the most conserved core sequence and surrounding consensus nucleotide sequence distribution). An EMSA was used to empirically determine whether this alteration of matrix similarity could affect the AP1 binding. As shown in Figure 5 , alleles AÀ161 and À161T exhibited different TF binding patterns. There are three specific binding complexes (I-III) for the AÀ161 probe, but only two (II and III) for the À161T probe. The absence of TF binding complex I for allele À161T may be relevant to the reduced transcriptional activity of the À161T allelic HTR1B promoter.
The AP1 family consists of homodimers and heterodimers of Jun (v-Jun, c-Jun, Jun B, Jun D), Fos (v-Fos, c-Fos, Fos B, Fra1, Fra 2), or activating TFs (ATF2, AFF3/LRF1, B-ATF), 45 therefore, the observed binding complexes may represent various AP1 complexes. Since c-Jun is a central component of AP1 complexes, 46 we investigated whether c-Jun is involved in the formation of any of the observed AP1 complexes. With the addition of antibody to c-Jun (noncrossreactive with Jun B or Jun D), only complex I was supershifted ( Figure 5) suggesting that a c-Jun binding site, present at AÀ161 but not À161T, is involved in the transcriptional activation of HTR1B in HCN-1A cells. In a supershift assay with antibody to c-Fos, we did not observed any supershifted band for either AÀ161 or À161T probe (data not shown), suggesting that c-Fos is not a component for the transcriptional regulation of HTR1B in HCN-1A cells.
Estimation of HTR1B haplotype frequencies
As À261G and À161T were found to be functional, and to have opposite effects, addressing the different configurations and frequencies of naturally existing haplotypes would be important for predicting the different functional haplotypes in a population. We used a sample of convenience that was composed of the unrelated parents not diagnosed with schizophrenia or schizoaffective disorder from the pedigrees. Compared to the larger European ancestry sample, the much smaller size of the African-American sample markedly limits the conclusions that can be made regarding allele and haplotype frequencies and tests of intermarker LD in this group, that is, the statistical power to detect effects and the likelihood any detected effects in this small sample would represent true positives. We estimated the haplotype frequencies and intermarker LD for TÀ261G, À182INS/ DELÀ181, and AÀ161T, and added to the analysis one synonymous SNP, G861C, which has been frequently used in association studies. In the European ancestry sample (representing B83% of the unaffected founders, see Table 1 ), 23.3% of the haplotypes contain both functional alleles with opposing and therefore nullifying effects, À261G and À161T (Table 1) , which indicates that typing both SNPs would be necessary in association experiments. However, there is still a substantial proportion of the haplotypes containing either À261G (about 22.6%) or À161T (about 7.3%), but not both. Haplotypes containing À261G without opposition from À161T are predicted to have an increased in vivo gene expression of HTR1B (Table 1 , Figure 2 ). In African Americans (representing B17% of the unaffected founders, see Table 1 ), the functional haplotypes containing either À261G or À161T, but not both, have a frequency of 13.4 or 5.7%, respectively. TÀ261G and AÀ161T were found at significant LD (D 0 ¼0.557, Po0.0001) in the European ancestry sample, while we found less significant LD (D 0 ¼0.381, P¼0.042) between TÀ261G and AÀ161T in the African-American sample (Table 2 ). In addition, we found that TÀ261G is in significant LD (D 0 ¼0.850, Po0.0001) with G861C in the European ancestry sample, which has also been found by a previous study, 47 but less significant LD in the African-American sample (D 0 ¼1.000, P¼0.011) ( Table  2) . We also observed significant LD (D 0 ¼0.687, Po0.0001) between AÀ161T and G861C in the European ancestry sample, but not in AfricanAmerican sample ( Table 2) . As all LD and haplotype frequency calculations were made based on the unrelated parents from schizophrenia pedigrees, but whom were not themselves diagnosed with schizophrenia or schizoaffective disorder, these data are an imperfect but approximate reflection of the true state of the populations from which they were drawn, at least for the European ancestry group.
Discussion
The functional characterization of 5 0 -UTR polymorphisms of HTR1B has relevance to the design and interpretation of association studies with HTR1B. First, AÀ161T and TÀ261G may be good candidate variants for association studies due to being functional. À161T has been shown to be nominally associated in a population-based study with alcohol dependence in Chinese Han, 15 and a family-based association study of schizophrenia also found a nominally significant association with AÀ161. 8 second, the functional effects of AÀ161T and TÀ261G could help to explain previous positive findings for association of the synonymous SNP G861C with various phenotypes and function. 13, [19] [20] [21] [22] [23] 48 LD has been observed among TÀ261G, AÀ161T, C129T, and G861C by us and by others. 8, 13, 14, 47 If any of the reported associations with G861C were confirmed, SNPs located in the HTR1B promoter may underlie the functional aspects of the association. In fact, TÀ261G is in LD with G861C, and on a population level most haplotypes that increase transcription contain both À261G and G861 (Table 1) . Our results provide a potential mechanistic explanation as to why individuals homozygous for the allele G861 have high B max values for HTR1B binding in prefrontal cortex. 13 However, we cannot rule out that there exist other still unknown, but functional, SNPs in HTR1B that are in LD with G861C, which may have an effect. It remains possible but unlikely that the synonymous SNP G861C may be functional by itself, such as was found for synonymous SNPs in dopamine receptor D2 (DRD2). 49 Few studies have so far addressed the functional impact of SNPs in regulatory regions on the control of human candidate gene expression. [50] [51] [52] [53] [54] [55] [56] [57] [58] We have demonstrated here that the common SNPs AÀ161T and TÀ261G in the HTR1B promoter region are functional in reporter gene assays. We provided evidence that HTR1B is regulated by AP1 and AP2. AP1 represents a family of TFs involved in cellular proliferation, transformation, and cell death, with cJun as a central component. 59 The AP2 TF family includes members of AP2-a, b, and g. AP2 acts as a transcriptional activator, and is thought to play a role in modulating neuron-and epithelium-specific genes. 60, 61 Our results also suggest that c-Jun may be important for transcriptional activation of HTR1B in HCN-1A cells, and that the active TF complex may not contain c-Fos. However, further experiments are needed to definitively demonstrate which AP1 TFs might be involved in the formation of the observed transcriptional complexes at the AÀ161T site. Actually, despite the increasing knowledge of the physiological role of AP1, major questions regarding the activity of individual AP1 proteins and their specificity remain unanswered. As a result, our understanding of the network of dynamic interactions between AP1 proteins and other TFs can be considered far from complete. 59 In addition to being a transcriptional activator, recent evidence indicates that c-Jun and other AP1 proteins can also repress gene transcription. 62, 63 Therefore, we cannot rule out that the functional effect of AÀ161T in HTR1B in other cell types or tissues may be different from what we have observed in HCN-1A cells. For example, it has been reported that the À161T allele increased transcriptional activity in a reporter gene assay in human colon adenocarcinoma (COLO 320 DM) cells, 15 which differs from our current observation made with human cortical neuron (HCN-1A) cells. Nevertheless, the absence of binding of c-Jun to the À161T probe ( Figure 5 ) in both the HCN-1A cells and CHO-K1 cells suggests that c-Jun plays a role as transcriptional activator for HTR1B and could explain the decrease of transcriptional activity for the À161T allele.
The two common variants TÀ261G and AÀ161T are very close to each other (100 bp) in the 5 0 -UTR of HTR1B and exhibit opposing effect on gene expression: their net functional effect on transcription is null when allele À261G and allele À161T are in the same haplotype. The two functional SNPs TÀ261G and AÀ161T are shown to be in significant LD in the European ancestry sample, and about 23.2% of the haplotypes contain both À261G and À161T (Tables 1  and 2 ). These data show a case where from a functional perspective, reliance on isolated SNPs is insufficient for the detailed analysis of genes. Our results are also consistent with previous work indicating that interactions of multiple SNPs within a haplotype might affect differently some cellular traits, as in the case of the human beta-2 adrenergic surface receptor (ADRB2) 49, 54 and DRD2. 49 We do not know whether the aforementioned in vitro effects of the HTR1B 5 0 -UTR polymorphisms TÀ261G and AÀ161T also occur in vivo or are detectable in heterozygotes. It has been suggested that inherited allelic variations in human gene expression are relatively common among individuals, 64 and that an allele leading to a modest change in expression may result in a predisposition to severe diseases. 65 It has been shown that a considerable number of the mouse genes contain functional regulatory variants affecting gene expression levels by at least 1.5-fold. 66 We expect that the in vivo effects of AÀ161T and TÀ261G may be more complicated than what we observed in our current in vitro study, because there may be other functional SNPs in HTR1B, and the analysis of variation in gene expression in vivo may be complicated by the effect of environmental or physiological differences between individuals. Quantitatively comparing the relative gene expression levels for two alleles within the same cellular sample from individuals who are heterozygous at the SNP site can help address this problem. 64, 66 Since HTR1B is involved in modulating the effects of serotonin (and indirectly other neurotransmitters), in vivo changes in HTR1B expression may considerably affect brain function and response to drugs.
